Showing 1 - 4 results of 4 for search 'Andreas D. Kistler', query time: 0.02s
Refine Results
-
1
The role of rituximab in the treatment of ANCA-associated vasculitides (AAV) by Thomas Daikeler, Andreas D. Kistler, Pierre-Yves Martin, Bruno Vogt, Uyen Huynh-Do
Published 2015-01-01
Article -
2
Correction: Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study. by Andreas D. Kistler, Andreas L. Serra, Justyna Siwy, Diane Poster, Fabienne Krauer, Vicente E. Torres, Michal Mrug, Jared J. Grantham, Kyongtae T. Bae, James E. Bost, William Mullen, Rudolf P. Wüthrich, Harald Mischak, Arlene B. Chapman
Published 2013-01-01
Article -
3
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. by Andreas D Kistler, Andreas L Serra, Justyna Siwy, Diane Poster, Fabienne Krauer, Vicente E Torres, Michal Mrug, Jared J Grantham, Kyongtae T Bae, James E Bost, William Mullen, Rudolf P Wüthrich, Harald Mischak, Arlene B Chapman
Published 2013-01-01
Article -
4
Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial. by Mathis Komminoth, Marc Y Donath, Matthias Hepprich, Philipp Schuetz, Claudine A Blum, Beat Mueller, Jean-Luc Reny, Pauline Gosselin, Gautier Breville, Michael Brändle, Christoph Henzen, Jörg D Leuppi, Andreas D Kistler, Robert Thurnheer, Felix Beuschlein, Gottfried Rudofsky, Daniel Aeberli, Peter M Villiger, Stephan Böhm, Irina Chifu, Martin Fassnacht, Gesine Meyer, Jörg Bojunga, Marco Cattaneo, Constantin Sluka, Helga Schneider, Jonas Rutishauser, «TOASST» study group
Published 2023-01-01
Article